Mavorixafor is a selective CXC chemokine receptor 4 (CXCR4) antagonist that binds to the CXCR4 receptor, preventing its interaction with CXCL12,1 which is currently approved in the United States under ...
LONDON, Feb. 24, 2026 /PRNewswire/ -- The largest-ever study of cardiac screening in young people has found that heart checks (using an electrocardiogram, ECG, a simple and yet very effective ...
We discuss Rocky Romero using Bullet Club logos in Impact and Mania cutouts, analyzing cross-promotional branding and ...
A new sticker sheet featuring holographic stickers to celebrate the 70th anniversary of Disneyland is now available for ...
Boasting series with stars such as Bella Ramsey, Brenda Blethyn, Shemar Moore and Catherine Zeta Jones and the latest titles from the creators of “Adolescence,” “Lupin,” “Narcos” and “Ozark,” the ...
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy ...